From a clinical point of view, in-depth studies are needed regarding the involvement of the bFGF/FGFR signaling axis in bladder cancer; this growth factor may represent an important biomarker for diagnostic purposes and contribute to the development of new therapeutic strategies. The gene discussed is FGF2; the disease is urinary bladder cancer.